TB-500 (Thymosin Beta-4)
TB-500 (Thymosin Beta-4) is a healing & repair peptide used in evidence-based, physician-supervised protocols. Use for widespread or systemic tissue repair (e.g., cardiac, neurological, connective tissue).
What is TB-500 (Thymosin Beta-4)?
Synthetic fragment of Thymosin Beta-4 (Ac-SDKP). Promotes actin polymerization, upregulates cell migration factors, reduces inflammation via NF-kB inhibition, stimulates stem cell homing. Systemic — does not need to be injected at injury site.
Uses & clinical decision logic
Use for widespread or systemic tissue repair (e.g., cardiac, neurological, connective tissue). Preferred over BPC-157 when injury is diffuse or inaccessible.
TB-500 (Thymosin Beta-4) dosage & administration
| Vial size | BAC water | Dosing range | Units / dose | Frequency | Route |
|---|---|---|---|---|---|
| 5mg | 1mL | 2.5-5mg | 50-100 units | 2x/week | SubQ |
| 10mg | 2mL | 2.5-5mg | 50-100 units | 2x/week | SubQ |
Safety & contraindications
Potential for wound-healing acceleration of latent cancerous tissue — rule out malignancy.
Stacking & combinations
Pairs with BPC-157 for synergistic cascade; combine with GH peptides during recovery phases.
Related peptides
Frequently asked questions
What is TB-500 (Thymosin Beta-4) used for?
Use for widespread or systemic tissue repair (e.g., cardiac, neurological, connective tissue). Preferred over BPC-157 when injury is diffuse or inaccessible.
What is the typical TB-500 (Thymosin Beta-4) dosage?
Common dosing ranges from 2.5-5mg (2x/week, SubQ). Exact dosing is individualized and set by a licensed physician.
How is TB-500 (Thymosin Beta-4) administered?
TB-500 (Thymosin Beta-4) is typically administered via SubQ.
What are the contraindications for TB-500 (Thymosin Beta-4)?
Potential for wound-healing acceleration of latent cancerous tissue — rule out malignancy.
Build a physician-supervised protocol around your goal — no gatekeeping, real doctors, 503A compounding pharmacies.
Build your protocol →This page is for educational purposes only and is not medical advice. Peptide therapies described here are provided under physician supervision through 503A compounding pharmacies. Many peptides are not FDA-approved for the uses described. Do not start, stop, or change any protocol without consulting a licensed physician.